Active treatment in high-risk, early-stage CLL or SLL.
Saved in:
| Title: | Active treatment in high-risk, early-stage CLL or SLL. |
|---|---|
| Authors: | Stephens DM; UNC School of Medicine, Chapel Hill, North Carolina. |
| Source: | Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2026 Jun; Vol. 24 (4), pp. 259-261. |
| Publication Type: | Interview |
| Journal Info: | Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
